Evidence map›Paper›PMID 42324908›Full record

ReviewMicrobiologyOpen2026

Pathogenic Mechanisms of V. vulnificus and Its Role in the Development of Sepsis.

Zhongying Yu, Xianzhong Zhu, Shijie Tang, Shubo Yang, Jinyu Li, Lianzhong Luo, Yan Tan, Jun Yin

Abstract readReview
In one paragraph

Review in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhongying YuDepartment of Urology, the 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, Fujian, China.ORCID 0009-0008-9092-7104
Xianzhong ZhuDepartment of Urology, the 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, Fujian, China.
Shijie TangDepartment of Urology, General Hospital of Xizang Military Command, Lhasa, Tibet, China.
Shubo YangDepartment of Urology, the 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, Fujian, China.
Jinyu LiDepartment of Urology, the 909th Hospital, School of Medicine, Xiamen University, Zhangzhou, Fujian, China.
Lianzhong LuoFujian Universities and Colleges Engineering Research Center of Marine Biopharmaceutical Resources, Xiamen Medical College, Xiamen, Fujian, China.
Yan TanDepartment of Pathophysiology, Army Medical University, Chongqing, China.
Jun YinDepartment of Pathophysiology, Army Medical University, Chongqing, China.

Funding

Natural Science Foundation of Fujian Province 2023J011834
6 · The paper itself

Abstract

Vibrio vulnificus (V. vulnificus) is a highly virulent marine pathogen responsible for severe infections, including necrotizing fasciitis and life-threatening sepsis, particularly in immunocompromised individuals. This review synthesizes current knowledge on V. vulnificus pathogenesis, focusing on key virulence factors such as cytolysins (VvhA and MARTX), iron acquisition systems, and immune evasion strategies. The bacterium's ability to induce rapid tissue damage, endothelial dysfunction, and systemic inflammation-mediated through cytokine storms and necroptosis-underpins V. vulnificus high mortality rates. Risk factors include chronic liver disease, diabetes, and environmental exposure to seafood harboring V. vulnificus or brackish water. Clinical management hinges on early diagnosis, prompt antibiotic therapy (e.g., doxycycline combined with third-generation cephalosporins), and surgical intervention for necrotizing infections. Despite advances, challenges persist, including antibiotic resistance and delayed diagnosis. Future directions emphasize novel therapeutics targeting virulence mechanisms, rapid diagnostics, and climate-adaptive public health strategies to curb the rising incidence of V. vulnificus infections in warming coastal ecosystems. This review underscores the urgent need for multidisciplinary approaches to mitigate the global burden of this formidable pathogen.

Indexed as

SepsisVibrio InfectionsVibrio vulnificusAnimalsAnti-Bacterial AgentsHumansImmune EvasionRisk FactorsVirulence FactorsAnti-Bacterial AgentsVirulence Factorsantimicrobial therapymarine pathogensnecrotizing fasciitissepsisvirulence factorsV. vulnificus

Identifiers

PMID42324908
PMCPMC13284543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.